MDSpire - MDSpire Home

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dental Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

February 6, 2026

Autism Diagnosis Timing Varies by Sex

Kathryn Wighton
February 6, 2026
3 min

Recent research shows that autism spectrum disorder (ASD) diagnoses are more prevalent in boys during childhood, while girls are often diagnosed later in adoles

...more

ASD diagnoses are more frequent in boys during childhood.
Girls often diagnosed later, in adolescence.
Study analyzed over 2.7 million individuals in Sweden.
Median age at diagnosis is 14.3 years.
Male-to-female diagnosis ratio declined over time.
Highest ASD incidence rates during 2020-
Limitations include reliance on registry data.
Systemic biases in diagnosis may affect autism recognition in females.

February 6, 2026

Tracking Opioid Refills After Surgery

Kathryn Wighton
February 6, 2026
4 min

A study analyzing opioid prescribing practices from 2017 to 2023 found that despite a decrease in discharge opioid prescriptions, opioid refill rates within 90

...more

Opioid prescribing reduced from 2017 to
Refills remained unchanged post-discharge.
Mismatches in prescribed vs. inpatient opioid doses increased refill risk.
Preoperative opioid use correlated with refills.
Prior refill strongest predictor of future refills.
Need for alignment in discharge prescriptions with inpatient consumption.
Study analyzed 4,132 adult patients in a large academic center.
Observational nature limits causal inferences.

Baptist Health South Florida

February 6, 2026

Baptist Health Miami Cancer Institute Names Bruna Pellini, M.D., Chief of Thoracic Medical Oncology

February 6, 2026
3 min

Dr. Bruna Pellini has been appointed chief of thoracic medical oncology at Baptist Health Miami Cancer Institute, bringing extensive experience in lung cancer t

...more

Dr. Bruna Pellini is the new chief of thoracic medical oncology.
She specializes in lung cancer treatment.
Formerly at Moffitt Cancer Center, she has extensive research experience.
Focus on liquid biopsy technologies for cancer care.
Authored over 40 peer-reviewed articles.
Participates in major oncology conferences and committees.
Patient care emphasizes communication and shared decision-making.

Baptist Health South Florida

February 6, 2026

Baptist Health Miami Cancer Institute Names Justin M. Dubin, M.D., Director of Men’s Health

February 6, 2026
2 min

Dr. Justin M. Dubin, a board-certified urologist, has joined Baptist Health Miami Cancer Institute as the director of Men’s Sexual Health. He specializes in tre

...more

Dr. Justin M. Dubin is the new director of Men's Sexual Health at Baptist Health Miami Cancer Institute. He specializes in male infertility and sexual health. He aims to reduce stigma around men's health issues. Dr. Dubin co-hosts the podcast 'Man Up.' He previously worked at Memorial Healthcare System. He prioritizes clear communication with patients. He has extensive experience in medical publications and presentations.

Baptist Health South Florida

February 6, 2026

Miami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual

February 6, 2026
2 min

A live symposium scheduled for March 6-7, 2026, at JW Marriott Miami focuses on advancements in hematologic malignancies, including leukemia, lymphoma, and mult

...more

Symposium on hematologic malignancies scheduled for March 6-7,
Location: JW Marriott Miami, FL.
Designed for oncologists, hematologists, oncology nurses, and pharmacists.
Focus on immunotherapies, stem cell transplantation, and treatment combinations.
Aim: improve understanding of new strategies and emerging data relevant to patient management.

February 6, 2026

Biomarkers Expand Precision in CRC

Julia Cipriano, MS, CMPP
February 6, 2026
5 min

Advancements in diagnostic, prognostic, and predictive biomarkers are transforming the management of colorectal cancer (CRC). Grounded in a narrative review by

...more

Established biomarkers like KRAS and MSI are critical in CRC management.
Emerging noninvasive tests include multitarget stool DNA and ctDNA assays.
Multi-omics integration aids in prognostic model development.
Predictive factors such as RAS mutations guide treatment selection.
Future challenges include validation trials and assay standardization.
Personalized CRC care can enhance patient outcomes through tailored interventions.

Baptist Health South Florida

February 6, 2026

World Cancer Day: Taking a Proactive Approach to the Most Commonly Diagnosed Cancer

February 6, 2026
6 min

Sue Perrin, a retired nurse, discovered a growth on her leg that was identified as basal cell carcinoma, the most common form of skin cancer. Choosing Baptist H

...more

Basal cell carcinoma is the most common skin cancer.
Early detection is key for a successful outcome.
Mohs surgery offers a high cure rate by removing cancerous cells layer by layer.
Sun exposure is the leading cause of basal cell carcinoma.
Ms. Perrin had successful treatment at Baptist Health Miami Cancer Institute.
Support from healthcare professionals is crucial during treatment.
Monitoring skin changes is essential for early diagnosis.

The Analytical Scientist

February 6, 2026

Waters at HPLC 2025

February 6, 2026
1 min

At the HPLC 2025 event, Waters introduced the Alliance iS, highlighting its innovative capabilities in chromatography technology. Attendees appreciated the even

...more

Waters introduced Alliance iS at HPLC
Event featured ice cream for attendees.
Focus on advancements in chromatography technology.
Aimed to engage professionals in analytical chemistry.
Showcased the future prospects in the field.

The Pathologist

February 6, 2026

When Other People’s Cells Become Our Own

February 6, 2026
3 min

Recent research published in Advanced Science explores microchimerism, where genetically distinct cells persist in the body, notably through pregnancy, twinning

...more

Microchimerism involves genetically distinct cells in the body.
It occurs during pregnancy and through medical procedures.
Detection methods are inadequate due to cell rarity.
Expert surveys identified key research questions.
PCR is a common detection method but has limitations.
Lack of standardized definitions complicates research.
The absence of reliable markers leads to inconsistent results.

The Analytical Scientist

February 6, 2026

Business-in-Brief: January 2026

February 6, 2026
3 min

Merck will acquire JSR Life Sciences' chromatography business to enhance the purification of monoclonal antibodies, with a deal expected to finalize by Q2 2026.

...more

Merck acquires JSR Lifesciences for protein chromatography.
Velaris strengthens automation by acquiring Markes International.
Shimadzu set to buy Tescan for $678 million.
Specac buys Amax Precision for enhanced OEM capabilities.
Thermo Fisher and NVIDIA collaborate to boost lab automation.

The Analytical Scientist

February 6, 2026

Alliance iS Demo: Smarter QC Workflows with Error Prevention

February 6, 2026
1 min

Andrea Gheduzzi, LC Market Development Manager at Waters Corporation, showcases the Alliance iS system, designed to revolutionize Quality Control (QC) lab opera

...more

Alliance iS transforms QC lab operations.
Guided sequences enhance user experience.
Automatic column recognition streamlines processes.
Enhanced autosampler design improves performance.
Built-in pre-run checks prevent costly errors.

The Pathologist

February 6, 2026

Meeting Growing Laboratory Demands With Digital Whole-Slide Imaging

February 6, 2026
1 min

Hamamatsu will showcase their innovative digital whole-slide imaging systems at ECP 2025 in Vienna, highlighting the advantages for laboratories engaged in both

...more

Hamamatsu will present at ECP 2025 in Vienna.
Focus on digital whole-slide imaging.
Systems include NanoZoomer and MoxiePlex.
Benefits for routine and research applications.
Improves imaging standards.
Helps manage increased lab workloads.
Reduces diagnostic turnaround times to hours.

The Analytical Scientist

February 6, 2026

Ronak Chawla on Innovation and the Future of the Analytical Lab

February 6, 2026
1 min

Ronak Chawla, Senior Director of Next-Generation LC Systems at Waters Corporation, highlights the capabilities of the Alliance iS in addressing contemporary lab

...more

Alliance iS reduces human error by up to 40%.
Features AI-powered anomaly detection.
Seamless workflows with intuitive design.
Offers end-to-end traceability.
Discussed by Ronak Chawla from Waters Corporation.

The Ophthalmologist

February 6, 2026

eyejourney: New AI Patient Platform Launched

February 6, 2026
2 min

Innoptix has introduced eyejourney, an innovative AI-driven patient education platform aimed at enhancing ophthalmic care. By addressing the issue that patients

...more

Innoptix launched eyejourney, an AI-powered patient education platform.
Designed to improve patient retention of consultation information.
Offers personalized videos created by surgeons using digital avatars.
Helps clinics manage patient anxiety and administrative burdens.
Provides multilingual support for diverse patient populations.

The Ophthalmologist

February 6, 2026

Searching for the Spectral Signature of Alzheimer’s

February 6, 2026
2 min

Recent research from the Istituto Italiano di Tecnologia in Rome highlights a significant advancement in Alzheimer's disease (AD) diagnosis through a novel tri-

...more

Tri-spectral imaging integrates with fundus cameras.
It captures data in blue, green, and red bands.
Study involved 38 patients with mild AD.
Initial results show increased blue reflectance in AD patients.
Machine learning model achieved AUC of 0.
Need for larger validation studies emphasized.

KFF Health News

February 6, 2026

Could Medicaid Data Deter Emergency Care?

Phil Galewitz
Amanda Seitz
February 6, 2026
8 min

The Trump administration's recent decision to grant ICE access to Medicaid data poses significant challenges for hospitals caring for immigrant patients. This m

...more

Trump administration allows ICE access to Medicaid data.
Concerns over patient confidentiality arise.
Emergency Medicaid covers urgent and pregnancy care for immigrants.
22 states have sued to block data-sharing agreements.
Patients may avoid treatment out of fear of deportation.
Judge's ruling limits ICE to information on unlawful residents.
Hospitals face ethical dilemmas regarding patient privacy.
Immigrants express fear of seeking medical assistance due to potential repercussions.

The Medicine Maker

February 6, 2026

The Role of AI in Rare Disease Drug Discovery

Dan Williams
February 6, 2026
11 min

Recent technological innovations, particularly in AI and gene therapy, are revolutionizing drug development for rare diseases. Despite significant challenges li

...more

Technological innovations are enhancing drug development processes.
AI aids in analyzing healthcare data, speeding up drug discovery.
Rare diseases pose special challenges due to their low patient populations.
Regulatory and economic factors affect rare disease drug development.
AI can distinguish symptoms of rare diseases from common ones.
Efficient data-sharing frameworks are essential for advancing treatment.
Early diagnosis can lead to better management and interventions.
Investing in AI for drug discovery is increasing markedly.

February 5, 2026

Surgical Sequencing in Esophageal Cancer

Margery Weinstein
February 5, 2026
3 min

A phase 3 clinical trial from Sichuan Cancer Hospital investigated treatment outcomes for locally advanced esophageal squamous cell carcinoma. Patients underwen

...more

The study compared neoadjuvant chemoradiotherapy and surgery with adjuvant therapy.
No significant overall survival difference was found.
Complete pathologic response greatly improved outcomes.
Similar adverse effect rates were observed between groups.
Tumor resection with negative margins was achieved in over 95% of patients.
Study limitations include single-center design and modest sample size.
Tailored treatment strategies are essential for optimal patient outcomes.

Advertisement

Advertisement

Recommended

Advertisement

About
Privacy Policy

Follow Us